Research Progress for Targeting Deubiquitinases in Gastric Cancers
Gastric cancers (GCs) are malignant tumors with a high incidence that threaten global public health. Despite advances in GC diagnosis and treatment, the prognosis remains poor. Therefore, the mechanisms underlying GC progression need to be identified to develop prognostic biomarkers and therapeutic...
Main Authors: | Tao An, Yanting Lu, Zhaoqi Gong, Yongtao Wang, Chen Su, Guimei Tang, Jingjing Hou |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/23/5831 |
Similar Items
-
The New Genetic Landscape of Cushing’s Disease: Deubiquitinases in the Spotlight
by: Silviu Sbiera, et al.
Published: (2019-11-01) -
E3 ubiquitin ligases and deubiquitinases in bladder cancer tumorigenesis and implications for immunotherapies
by: Maoyu Wang, et al.
Published: (2023-07-01) -
Targeting deubiquitinases for cancer therapy
by: Qian Xue, et al.
Published: (2023-10-01) -
A review of deubiquitinases and thier roles in tumorigenesis and development
by: Xian-Wen Liang, et al.
Published: (2023-05-01) -
Role of Deubiquitinases in Human Cancers: Potential Targeted Therapy
by: Keng Po Lai, et al.
Published: (2020-04-01)